Schroder Investment Management Group’s Arcus Biosciences RCUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-15,485
| Closed | -$315K | – | 1237 |
|
|
2023
Q2 | $315K | Sell |
15,485
-249,579
| -94% | -$5.07M | ﹤0.01% | 1160 |
|
|
2023
Q1 | $4.83M | Buy |
265,064
+148,932
| +128% | +$2.72M | 0.01% | 791 |
|
|
2022
Q4 | $2.4M | Sell |
116,132
-1,410
| -1% | -$29.2K | ﹤0.01% | 910 |
|
|
2022
Q3 | $3.08M | Buy |
117,542
+88,849
| +310% | +$2.32M | 0.01% | 863 |
|
|
2022
Q2 | $700K | Buy |
+28,693
| New | +$700K | ﹤0.01% | 1128 |
|